Meta's Superintelligence Team will be spearheaded by AI Genius Alexandr Wang who works as the chief AI officer.

Bootstrap Bio, created about 18 months ago, is working on technology to change the DNA in an embryo, according to two people familiar with the company and one of its investors.

Customer Momentum "The new editor brings everything into one place — code, pipeline graph, results, configuration, and troubleshooting. No more juggling browser tabs or losing context.

Passage Bio Reports Positive Interim Data from Phase 1/2 upliFT-D Trial of PBFT02 for Frontotemporal Dementia June 23, 2025 — 07:13 am EDT Written by None for Quiver Quantitative -> ...

In October 2023, the biotech opted to cut one in five of its workforce and shelve R&D programmes to focus on BEAM-101, along with its BEAM-302 base-editing candidate for alpha-1 antitrypsin ...

Shares of Bio-Techne Corp. TECH slipped 4.13% to $49.50 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.84% to 5,982.72 ...

As biopharmaceutical manufacturing shifts towards continuous manufacturing, “Implementation of process analytical technology (PAT) in downstream processing has been somewhat limited,” the team ...

The Novo Nordisk programme will focus on the use of Bluebird’s gene-editing platform – called megaTAL – to interact with genes within the body (in vivo) after systemic dosing.